BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35981602)

  • 21. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
    Wan Q; Sang X; Jin L; Wang Z
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Ferroptosis-Associated Gene Signature to Predict Prognosis in Patients with Uveal Melanoma.
    Luo H; Ma C
    Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33540700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of immune-related risk signature for uveal melanoma.
    Zhang Z; Ni Y; Chen G; Wei Y; Peng M; Zhang S
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):912-919. PubMed ID: 32496920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoacylglycerol lipase regulates macrophage polarization and cancer progression in uveal melanoma and pan-cancer.
    Tan Y; Pan J; Deng Z; Chen T; Xia J; Liu Z; Zou C; Qin B
    Front Immunol; 2023; 14():1161960. PubMed ID: 37033945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma.
    Xin X; Zhang Y; Ling F; Wang L; Sheng X; Qin L; Zhao X
    Exp Eye Res; 2019 Mar; 180():242-249. PubMed ID: 30615885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of Aneuploidy in Predicting Prognosis and Treatment Response of Uveal Melanoma.
    Zhang X; Jin L; Zhou C; Liu J; Jiang Q
    Curr Med Chem; 2024 Mar; ():. PubMed ID: 38504568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma.
    Li Y; Xiong C; Wu LL; Zhang BY; Wu S; Chen YF; Xu QH; Liao HF
    Pathol Oncol Res; 2023; 29():1610980. PubMed ID: 37362244
    [No Abstract]   [Full Text] [Related]  

  • 28. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
    Zhan Z; Lin K; Wang T
    BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of a hypoxia-immune-related prognostic panel based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer.
    Deng C; Deng G; Chu H; Chen S; Chen X; Li X; He Y; Sun C; Zhang C
    Front Immunol; 2023; 14():1140328. PubMed ID: 37180146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of prognostic genes in uveal melanoma microenvironment.
    Luo H; Ma C
    PLoS One; 2020; 15(11):e0242263. PubMed ID: 33196683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated analysis reveals the dysfunction of signaling pathways in uveal melanoma.
    Sun S; Guo B; Xu L; Shi R
    BMC Cancer; 2022 Jul; 22(1):734. PubMed ID: 35790930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma.
    Cheng Y; Liu J; Fan H; Liu K; Zou H; You Z
    Front Genet; 2022; 13():1050341. PubMed ID: 36544483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
    Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
    Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Validation of a Novel Metabolic Signature-Based Prognostic Model for Uveal Melanoma.
    Shi K; Li X; Zhang J; Sun X
    Transl Vis Sci Technol; 2022 May; 11(5):9. PubMed ID: 35536719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of a Promising Tumor-Infiltrating CD8+ T Cells Gene Signature to Improve Prediction of the Prognosis and Immune Response of Uveal Melanoma.
    Sun Y; Wu J; Yuan Y; Lu Y; Luo M; Lin L; Ma S
    Front Cell Dev Biol; 2021; 9():673838. PubMed ID: 34124058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and Validation of a Novel Immunosignature for Overall Survival in Uveal Melanoma.
    Gu C; Gu X; Wang Y; Yao Z; Zhou C
    Front Cell Dev Biol; 2021; 9():710558. PubMed ID: 34552928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated ZNF704 expression is associated with poor prognosis of uveal melanoma and promotes cancer cell growth by regulating AKT/mTOR signaling.
    Luo J; Li H; Xiu J; Zeng J; Feng Z; Zhao H; Li Y; Wei W
    Biomark Res; 2023 Apr; 11(1):38. PubMed ID: 37038184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.
    Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J
    Front Immunol; 2022; 13():922315. PubMed ID: 35774794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic values of m6A RNA methylation regulators in uveal melanoma.
    Tang J; Wan Q; Lu J
    BMC Cancer; 2020 Jul; 20(1):674. PubMed ID: 32682400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-Wide Analysis of Uveal Melanoma Metastasis-Associated LncRNAs and Their Functional Network.
    Xu B; Ma R; Ren H; Qian J
    DNA Cell Biol; 2018 Feb; 37(2):99-108. PubMed ID: 29240458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.